Connect with us

Tech

PharmEasy Sells 10% Stake In Thyrocare For INR 668 Cr

Published

on

[ad_1]

SUMMARY

PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal

The company raked in a total of INR 667.7 Cr share via the block deal, which valued each share at INR 1,252.03

Following this transaction, PharmEasy’s ownership in Thyrocare will reduce to 60.93% from the 70.98% stake it held previously

Distressed healthtech startup PharmEasy’s subsidiary Docon Technologies has offloaded…

[ad_2]

Source link

Continue Reading